Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures

NCT06199492•M.D. Anderson Cancer Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Needle Biopsy

Interventions

tVisio-1

Locations

United States

Locations (1)

MD Anderson Cancer Center

Houston, Texas, United States

Key Dates

Start Date

December 5, 2024

Primary Completion Date

May 31, 2027

Completion Date

May 31, 2027

Last Updated

January 14, 2026

Contacts

Rahul A Sheth, MD

CONTACT

(713) 745-0652 rasheth@mdanderson.org

Sponsors

Lead Sponsor

M.D. Anderson Cancer Center

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 14, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions